{"id":450,"date":"2026-08-27T10:31:11","date_gmt":"2026-08-27T10:31:11","guid":{"rendered":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/"},"modified":"2026-08-28T07:42:46","modified_gmt":"2026-08-28T07:42:46","slug":"retatrutide-development-status-2026-evidence-map","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/ar\/retatrutide-development-status-2026-evidence-map\/","title":{"rendered":"\u062d\u0627\u0644\u0629 \u062a\u0637\u0648\u0631 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u0627\u064a\u062f \u0641\u064a \u0639\u0627\u0645 2026: \u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0644\u0628\u0627\u062d\u062b\u064a\u0646"},"content":{"rendered":"

\u062a\u062e\u0644\u0642 \u0645\u0631\u0643\u0628\u0627\u062a \u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062a\u0637\u0648\u064a\u0631 \u0645\u0634\u0643\u0644\u0629 \u062f\u0642\u0629 SEO \u0645\u062a\u0643\u0631\u0631\u0629: \u063a\u0627\u0644\u0628\u064b\u0627 \u0645\u0627 \u064a\u062a\u0645 \u062f\u0645\u062c \u0625\u0639\u0644\u0627\u0646\u0627\u062a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0648\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0633\u062c\u064a\u0644 \u0648\u062a\u0642\u0627\u0631\u064a\u0631 \u0627\u0644\u0645\u0624\u062a\u0645\u0631\u0627\u062a \u0648\u0645\u0642\u0627\u0644\u0627\u062a \u0627\u0644\u0645\u062c\u0644\u0627\u062a \u0648\u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0627\u062a \u0641\u064a \u062c\u062f\u0648\u0644 \u0632\u0645\u0646\u064a \u0648\u0627\u062d\u062f. \u062a\u062d\u0627\u0641\u0638 \u062e\u0631\u064a\u0637\u0629 \u0627\u0644\u0623\u062f\u0644\u0629 \u0647\u0630\u0647 \u0639\u0644\u0649 \u0647\u0630\u0647 \u0627\u0644\u0645\u0639\u0627\u0644\u0645 \u0645\u0646\u0641\u0635\u0644\u0629 \u0639\u0646 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u064a\u062f.<\/p>

\u0627\u0644\u0648\u062c\u0628\u0627\u062a \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629<\/h2>
  • \u0625\u0646 \u0646\u062a\u0627\u0626\u062c 2 \u0644\u0645\u0631\u062d\u0644\u0629 \u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0646\u0638\u0631\u0627\u0621 \u0648\u0633\u062c\u0644 \u062a\u0633\u062c\u064a\u0644 3 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0645\u0643\u062a\u0645\u0644\u0629 \u0647\u0645\u0627 \u0643\u0627\u0626\u0646\u0627\u0646 \u062f\u0644\u064a\u0644\u0627\u0646 \u0645\u062e\u062a\u0644\u0641\u0627\u0646.<\/li>
  • \u0644\u0627 \u064a\u0632\u0627\u0644 \u0645\u0648\u0642\u0639 ClinicalTrials.gov \u0644\u0627 \u064a\u064f\u0638\u0647\u0631 \u0623\u064a \u0646\u062a\u0627\u0626\u062c \u0645\u0646\u0634\u0648\u0631\u0629 \u0644\u0640 TRIUMPH-1\u060c \u0641\u064a \u062d\u064a\u0646 \u0623\u0646 \u0627\u0644\u0625\u0641\u0635\u0627\u062d\u0627\u062a \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0631\u0639\u0627\u064a\u0629 2026 \u0645\u0648\u062c\u0648\u062f\u0629 \u0627\u0644\u0622\u0646\u061b \u064a\u062a\u0645 \u0627\u0644\u0625\u0628\u0644\u0627\u063a \u0639\u0646 \u0643\u0627\u0626\u0646\u0627\u062a \u0627\u0644\u0623\u062f\u0644\u0629 \u0647\u0630\u0647 \u0628\u0634\u0643\u0644 \u0645\u0646\u0641\u0635\u0644 \u0623\u062f\u0646\u0627\u0647.<\/li>
  • \u064a\u062c\u0628 \u0627\u0644\u062a\u062d\u0642\u0642 \u0645\u0646 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629 \u0645\u0642\u0627\u0628\u0644 \u0633\u062c\u0644\u0627\u062a FDA\u060c \u0648\u0644\u064a\u0633 \u0627\u0644\u0627\u0633\u062a\u062f\u0644\u0627\u0644 \u0639\u0644\u064a\u0647\u0627 \u0645\u0646 \u0627\u0644\u062a\u063a\u0637\u064a\u0629 \u0627\u0644\u0625\u0639\u0644\u0627\u0645\u064a\u0629 \u0623\u0648 \u062a\u0648\u0641\u0631 \u0627\u0644\u0643\u062a\u0627\u0644\u0648\u062c.<\/li><\/ul><\/div><\/div>
    \"\u0628\u0627\u062d\u062b
    \u0627\u0644\u062a\u0648\u0636\u064a\u062d \u0627\u0644\u0645\u0641\u0627\u0647\u064a\u0645\u064a \u0644\u0644\u0628\u062d\u0648\u062b \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a\u061b \u0644\u0645 \u064a\u062a\u0645 \u062a\u0635\u0648\u064a\u0631 \u0623\u064a \u0646\u062a\u064a\u062c\u0629 \u062a\u062c\u0631\u064a\u0628\u064a\u0629 \u0623\u0648 \u0639\u0631\u0636 \u062a\u0642\u062f\u064a\u0645\u064a \u0644\u0644\u0645\u0646\u062a\u062c.<\/figcaption><\/figure>

    \u0633\u0644\u0645 \u0627\u0644\u0623\u062f\u0644\u0629<\/h2>

    \u064a\u062c\u064a\u0628 \u0633\u062c\u0644 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0639\u0644\u0649 \u0623\u0633\u0626\u0644\u0629 \u0627\u0644\u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644 \u0648\u0627\u0644\u062d\u0627\u0644\u0629: \u0645\u0627 \u0627\u0644\u0630\u064a \u062a\u0645 \u0627\u0644\u062a\u062e\u0637\u064a\u0637 \u0644\u0647\u060c \u0648\u0645\u0646 \u0643\u0627\u0646 \u0645\u0624\u0647\u0644\u0627\u064b\u060c \u0648\u0645\u0627 \u0647\u064a \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u062a\u064a \u062a\u0645 \u062a\u062d\u062f\u064a\u062f\u0647\u0627\u060c \u0648\u0645\u0627 \u0625\u0630\u0627 \u0643\u0627\u0646 \u0627\u0644\u062a\u0648\u0638\u064a\u0641 \u0623\u0648 \u0627\u0644\u0645\u062a\u0627\u0628\u0639\u0629 \u0645\u0643\u062a\u0645\u0644\u064a\u0646. \u062a\u062c\u064a\u0628 \u0645\u0642\u0627\u0644\u0629 \u0641\u064a \u0645\u062c\u0644\u0629 \u0639\u0644\u0649 \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u062e\u062a\u0644\u0641\u0629 \u0645\u0646 \u0627\u0644\u0623\u0633\u0626\u0644\u0629 \u0628\u0639\u062f \u062a\u062d\u0644\u064a\u0644 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0648\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0646\u0638\u0631\u0627\u0621. \u064a\u0636\u064a\u0641 \u0633\u062c\u0644 \u0645\u0648\u0627\u0641\u0642\u0629 FDA \u0642\u0631\u0627\u0631\u064b\u0627 \u062a\u0646\u0638\u064a\u0645\u064a\u064b\u0627 \u0645\u0633\u062a\u0642\u0644\u0627\u064b \u0644\u0645\u0646\u062a\u062c \u0645\u0639\u064a\u0646.<\/p>

    \u062a\u0645 \u0627\u0644\u0646\u0634\u0631<\/strong>\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 2 \u0644\u0644\u0633\u0645\u0646\u0629 \u0645\u0639 \u0646\u062a\u0627\u0626\u062c \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627 \u0645\u0646 \u0642\u0628\u0644 \u0627\u0644\u0646\u0638\u0631\u0627\u0621<\/span><\/div>
    \u0645\u0633\u062c\u0644\/\u0645\u0643\u062a\u0645\u0644<\/strong>\u0645\u0631\u062d\u0644\u0629 TRIUMPH-1 \u0633\u062c\u0644 3\u061b \u0645\u0639\u0644\u0648\u0645\u0627\u062a \u0627\u0644\u062d\u0627\u0644\u0629 \u0648\u0627\u0644\u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644<\/span><\/div>
    \u0623\u0641\u0627\u062f \u0627\u0644\u0631\u0627\u0639\u064a<\/strong>\u0646\u062a\u0627\u0626\u062c 2026 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 3\u061b \u0644\u0645 \u064a\u062a\u0645 \u0628\u0639\u062f \u062a\u0642\u062f\u064a\u0645 \u0627\u0644\u062a\u0642\u0627\u0631\u064a\u0631 \u0627\u0644\u0643\u0627\u0645\u0644\u0629 \u0644\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0646\u0638\u0631\u0627\u0621<\/span><\/div>
    ClinicalTrials.gov<\/strong>\u0644\u0627 \u064a\u0632\u0627\u0644 TRIUMPH-1 \u064a\u0639\u0631\u0636 \u0639\u062f\u0645 \u0646\u0634\u0631 \u0623\u064a \u0646\u062a\u0627\u0626\u062c<\/span><\/div>
    \u0644\u0645 \u064a\u062a\u0645 \u062a\u0623\u0633\u064a\u0633\u0647\u0627<\/strong>\u0645\u0648\u0627\u0641\u0642\u0629 FDA \u0639\u0644\u0649 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u064a\u062f<\/span><\/div><\/div><\/div>

    \u0643\u064a\u0641\u064a\u0629 \u062a\u062d\u062f\u064a\u062b \u0647\u0630\u0647 \u0627\u0644\u0635\u0641\u062d\u0629 \u0628\u0645\u0633\u0624\u0648\u0644\u064a\u0629<\/h2>

    \u0639\u0646\u062f\u0645\u0627 \u064a\u062a\u063a\u064a\u0631 \u0627\u0644\u0633\u062c\u0644\u060c \u0642\u0645 \u0628\u062a\u0633\u062c\u064a\u0644 \u062a\u0627\u0631\u064a\u062e \u0627\u0644\u062a\u062d\u062f\u064a\u062b \u0648\u0648\u0635\u0641 \u0627\u0644\u062d\u0642\u0644 \u0627\u0644\u0630\u064a \u062a\u0645 \u062a\u063a\u064a\u064a\u0631\u0647 \u0641\u0642\u0637. \u0639\u0646\u062f\u0645\u0627 \u062a\u0638\u0647\u0631 \u0627\u0644\u0646\u062a\u0627\u0626\u062c\u060c \u0642\u0645 \u0628\u0631\u0628\u0637 \u0633\u062c\u0644 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0623\u0648 \u0627\u0644\u0645\u0646\u0634\u0648\u0631 \u0627\u0644\u062e\u0627\u0636\u0639 \u0644\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0646\u0638\u0631\u0627\u0621 \u0648\u062a\u0645\u064a\u064a\u0632 \u0646\u0642\u0627\u0637 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0645\u062d\u062f\u062f\u0629 \u0645\u0633\u0628\u0642\u064b\u0627 \u0639\u0646 \u0627\u0644\u062a\u062d\u0644\u064a\u0644\u0627\u062a \u0627\u0644\u0627\u0633\u062a\u0643\u0634\u0627\u0641\u064a\u0629. \u0639\u0646\u062f\u0645\u0627 \u062a\u062a\u063a\u064a\u0631 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629\u060c \u0627\u0633\u062a\u0628\u062f\u0644 \u0628\u064a\u0627\u0646 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0642\u062f\u064a\u0645\u060c \u0648\u0644\u064a\u0633 \u0645\u062c\u0631\u062f \u0625\u0644\u062d\u0627\u0642\u0647 \u0628\u0647.<\/p>

    \u0644\u0627 \u062a\u0642\u0645 \u0628\u062a\u062d\u062f\u064a\u062b \u062a\u0627\u0631\u064a\u062e \u0627\u0644\u0645\u0642\u0627\u0644\u0629 \u062f\u0648\u0646 \u062a\u063a\u064a\u064a\u0631 \u0627\u0644\u0623\u062f\u0644\u0629 \u0627\u0644\u0645\u0648\u0636\u0648\u0639\u064a\u0629. \u062a\u062d\u0630\u0631 \u0625\u0631\u0634\u0627\u062f\u0627\u062a \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u0623\u0648\u0644\u0627\u064b \u0645\u0646 Google \u0635\u0631\u0627\u062d\u0629\u064b \u0645\u0646 \u062a\u063a\u064a\u064a\u0631 \u0627\u0644\u062a\u0648\u0627\u0631\u064a\u062e \u0641\u0642\u0637 \u0644\u062c\u0639\u0644 \u0627\u0644\u0645\u062d\u062a\u0648\u0649 \u064a\u0628\u062f\u0648 \u062c\u062f\u064a\u062f\u064b\u0627.<\/p>

    2026 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062a\u064a \u0623\u0628\u0644\u063a \u0639\u0646\u0647\u0627 \u0627\u0644\u0631\u0627\u0639\u064a 3 \u0627\u0644\u062e\u0637 \u0627\u0644\u0639\u0644\u0648\u064a<\/h2>

    \u0623\u0628\u0644\u063a\u062a \u0634\u0631\u0643\u0629 Lilly \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0631\u0626\u064a\u0633\u064a\u0629 \u0644\u0640 TRIUMPH-1 \u0641\u064a \u0645\u0627\u064a\u0648 21\u060c 2026: \u0641\u064a \u0623\u0633\u0627\u0628\u064a\u0639 80\u060c \u0623\u0628\u0644\u063a \u0627\u0644\u0631\u0627\u0639\u064a \u0639\u0646 \u0645\u062a\u0648\u0633\u0637 \u200b\u200b\u062a\u063a\u064a\u0631 \u0641\u064a \u0627\u0644\u0648\u0632\u0646 \u0642\u062f\u0631\u0647 \u221228.3% \u0644\u0645\u062c\u0645\u0648\u0639\u0629 12 mg. \u0641\u064a \u064a\u0648\u0644\u064a\u0648\u060c \u0623\u0628\u0644\u063a\u062a 23\u060c 2026\u060c Lilly \u0639\u0646 \u062a\u063a\u064a\u064a\u0631\u0627\u062a \u0645\u062a\u0648\u0633\u0637\u0629 \u062a\u0635\u0644 \u0625\u0644\u0649 \u221220.8% \u0641\u064a TRIUMPH-2 \u0648-22.6% \u0641\u064a TRIUMPH-3. \u0647\u0630\u0647 \u0647\u064a \u0625\u0641\u0635\u0627\u062d\u0627\u062a \u0627\u0644\u0631\u0627\u0639\u064a \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u060c \u0648\u0644\u064a\u0633\u062a \u0648\u062d\u062f\u0627\u062a \u0646\u062a\u0627\u0626\u062c ClinicalTrials.gov \u0623\u0648 \u0627\u0644\u062a\u0642\u0627\u0631\u064a\u0631 \u0627\u0644\u0643\u0627\u0645\u0644\u0629 \u0627\u0644\u062a\u064a \u0631\u0627\u062c\u0639\u0647\u0627 \u0627\u0644\u0646\u0638\u0631\u0627\u0621\u061b \u0644\u0627 \u062a\u0632\u0627\u0644 \u0627\u0644\u0623\u0633\u0627\u0644\u064a\u0628 \u0627\u0644\u062a\u0641\u0635\u064a\u0644\u064a\u0629 \u0648\u0642\u0631\u0627\u0631\u0627\u062a \u0627\u0644\u062a\u062d\u0644\u064a\u0644 \u0648\u062c\u062f\u0627\u0648\u0644 \u0627\u0644\u0623\u062d\u062f\u0627\u062b \u0627\u0644\u0633\u0644\u0628\u064a\u0629 \u0627\u0644\u0643\u0627\u0645\u0644\u0629 \u062a\u062a\u0637\u0644\u0628 \u0627\u0644\u0633\u062c\u0644\u0627\u062a \u0627\u0644\u0643\u0627\u0645\u0644\u0629 \u0627\u0644\u0646\u0647\u0627\u0626\u064a\u0629. \u0648\u0627\u0635\u0644 \u0645\u0648\u0642\u0639 ClinicalTrials.gov \u0639\u0631\u0636 \"\u0644\u0645 \u064a\u062a\u0645 \u0646\u0634\u0631 \u0623\u064a \u0646\u062a\u0627\u0626\u062c\" \u0644\u0640 TRIUMPH-1 \u0641\u064a \u0647\u0630\u0647 \u0627\u0644\u0645\u0631\u0627\u062c\u0639\u0629.<\/p>

    \u0627\u0644\u0622\u062b\u0627\u0631 \u0627\u0644\u0645\u062a\u0631\u062a\u0628\u0629 \u0639\u0644\u0649 \u0635\u0641\u062d\u0627\u062a \u0627\u0644\u0628\u062d\u062b \u0627\u0644\u0643\u062a\u0627\u0644\u0648\u062c<\/h2>

    \u064a\u0645\u0643\u0646 \u0644\u0635\u0641\u062d\u0629 \u0627\u0644\u0643\u062a\u0627\u0644\u0648\u062c \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u062c\u062f\u0648\u0644 \u0627\u0644\u0632\u0645\u0646\u064a \u0644\u0644\u062a\u0637\u0648\u064a\u0631 \u0644\u062a\u0648\u062c\u064a\u0647 \u0627\u0644\u0628\u0627\u062d\u062b\u064a\u0646\u060c \u0648\u0644\u0643\u0646 \u064a\u062c\u0628 \u0623\u0646 \u062a\u062d\u0627\u0641\u0638 \u0639\u0644\u0649 \u0627\u0644\u0641\u0635\u0644 \u0628\u064a\u0646 \u0623\u062f\u0644\u0629 \u0627\u0644\u0623\u062f\u0628\u064a\u0627\u062a \u0648\u062c\u0648\u062f\u0629 \u0627\u0644\u062f\u0641\u0639\u0629. \u0648\u064a\u062c\u0628 \u0623\u0646 \u062a\u0631\u062a\u0628\u0637 \u0628\u0645\u0648\u0627\u0635\u0641\u0627\u062a \u0627\u0644\u0623\u0633\u0631\u0629 \u0648\u0648\u062d\u062f\u0627\u062a \u0627\u0644\u0623\u062f\u0644\u0629\u060c \u0648\u064a\u062c\u0628 \u0623\u0646 \u062a\u0634\u064a\u0631 \u0625\u0644\u0649 \u0623\u0646 \u0627\u0644\u0645\u0627\u062f\u0629 \u0644\u064a\u0633\u062a \u0644\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0628\u0634\u0631\u064a \u0623\u0648 \u0627\u0644\u0628\u064a\u0637\u0631\u064a.<\/p>","protected":false},"excerpt":{"rendered":"

    \u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0639\u0627\u0645 2026 \u062a\u0641\u0635\u0644 \u0628\u064a\u0646 \u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0645\u0646 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u064a\u062f\u060c \u0648\u0633\u062c\u0644\u0627\u062a \u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0644\u062b\u0629 \u0627\u0644\u0645\u0643\u062a\u0645\u0644\u0629\u060c \u0648\u0627\u0644\u0646\u062a\u0627\u0626\u062c \u063a\u064a\u0631 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0648\u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629.<\/p>","protected":false},"author":1,"featured_media":620,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"359","pim_article_type":"Development-status evidence map","pim_evidence_level":"Trial registry, peer-reviewed phase 2 evidence and FDA status","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Retatrutide phase 2 trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\",\"note\":\"Peer-reviewed outcomes.\"},{\"title\":\"TRIUMPH-1 ClinicalTrials.gov record\",\"url\":\"https:\/\/clinicaltrials.gov\/study\/NCT05929066\",\"note\":\"Protocol and current study-status record.\"},{\"title\":\"FDA current information on retatrutide status\",\"url\":\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss\",\"note\":\"Authoritative regulatory boundary.\"},{\"title\":\"TRIUMPH-1 sponsor-reported topline results\",\"url\":\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss\",\"note\":\"Lilly primary-sponsor news release, May 21, 2026; not a peer-reviewed full report.\"},{\"title\":\"TRIUMPH-2 and TRIUMPH-3 sponsor-reported topline results\",\"url\":\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-triple-agonist-retatrutide-successful-two-additional\",\"note\":\"Lilly primary-sponsor news release, July 23, 2026; detailed results remain pending.\"},{\"title\":\"Google guidance on people-first content and substantive date changes\",\"url\":\"https:\/\/developers.google.com\/search\/docs\/fundamentals\/creating-helpful-content\",\"note\":\"Official Google Search Central guidance cited for the editorial-update statement.\"}]","footnotes":""},"categories":[18],"tags":[],"class_list":["post-450","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-reviews"],"yoast_head":"\nRetatrutide Development Status in 2026: An Evidence Map for Researchers - NHD<\/title>\n<meta name=\"description\" content=\"A 2026 evidence map separating published retatrutide phase 2 data, completed phase 3 study records, unposted results and regulatory status.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ar\/retatrutide-development-status-2026-evidence-map\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retatrutide Development Status in 2026: An Evidence Map for Researchers\" \/>\n<meta property=\"og:description\" content=\"A 2026 evidence map separating published retatrutide phase 2 data, completed phase 3 study records, unposted results and regulatory status.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ar\/retatrutide-development-status-2026-evidence-map\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T10:31:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:42:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u062a\u0627\u0646\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Retatrutide Development Status in 2026: An Evidence Map for Researchers\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:42:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/\"},\"wordCount\":407,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/retatrutide-development-status-2026-evidence-map-featured-v2.webp\",\"articleSection\":[\"Evidence Reviews\"],\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/\",\"name\":\"Retatrutide Development Status in 2026: An Evidence Map for Researchers - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/retatrutide-development-status-2026-evidence-map-featured-v2.webp\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:42:46+00:00\",\"description\":\"A 2026 evidence map separating published retatrutide phase 2 data, completed phase 3 study records, unposted results and regulatory status.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/retatrutide-development-status-2026-evidence-map-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/retatrutide-development-status-2026-evidence-map-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/retatrutide-development-status-2026-evidence-map\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Retatrutide Development Status in 2026: An Evidence Map for Researchers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/ar\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u062d\u0627\u0644\u0629 \u062a\u0637\u0648\u0631 Retatrutide \u0641\u064a 2026: \u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0644\u0628\u0627\u062d\u062b\u064a\u0646 - NHD","description":"\u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0639\u0627\u0645 2026 \u062a\u0641\u0635\u0644 \u0628\u064a\u0646 \u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0645\u0646 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u064a\u062f\u060c \u0648\u0633\u062c\u0644\u0627\u062a \u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0644\u062b\u0629 \u0627\u0644\u0645\u0643\u062a\u0645\u0644\u0629\u060c \u0648\u0627\u0644\u0646\u062a\u0627\u0626\u062c \u063a\u064a\u0631 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0648\u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ar\/retatrutide-development-status-2026-evidence-map\/","og_locale":"ar_AR","og_type":"article","og_title":"Retatrutide Development Status in 2026: An Evidence Map for Researchers","og_description":"A 2026 evidence map separating published retatrutide phase 2 data, completed phase 3 study records, unposted results and regulatory status.","og_url":"https:\/\/nhdbio.com\/ar\/retatrutide-development-status-2026-evidence-map\/","og_site_name":"NHD","article_published_time":"2026-08-27T10:31:11+00:00","article_modified_time":"2026-08-28T07:42:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"NHD Technical Team","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u062a\u0627\u0646"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Retatrutide Development Status in 2026: An Evidence Map for Researchers","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:42:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/"},"wordCount":407,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp","articleSection":["Evidence Reviews"],"inLanguage":"ar","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/","url":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/","name":"\u062d\u0627\u0644\u0629 \u062a\u0637\u0648\u0631 Retatrutide \u0641\u064a 2026: \u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0644\u0628\u0627\u062d\u062b\u064a\u0646 - NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:42:46+00:00","description":"\u062e\u0631\u064a\u0637\u0629 \u0623\u062f\u0644\u0629 \u0644\u0639\u0627\u0645 2026 \u062a\u0641\u0635\u0644 \u0628\u064a\u0646 \u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0645\u0646 \u0631\u064a\u062a\u0627\u062a\u0631\u0648\u062a\u064a\u062f\u060c \u0648\u0633\u062c\u0644\u0627\u062a \u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0644\u062b\u0629 \u0627\u0644\u0645\u0643\u062a\u0645\u0644\u0629\u060c \u0648\u0627\u0644\u0646\u062a\u0627\u0626\u062c \u063a\u064a\u0631 \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0648\u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/retatrutide-development-status-2026-evidence-map-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/retatrutide-development-status-2026-evidence-map\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Retatrutide Development Status in 2026: An Evidence Map for Researchers"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u0645\u0648\u0627\u062f \u062e\u0627\u0645 \u0628\u0628\u062a\u064a\u062f\u064a\u0629 \u0648\u062a\u062e\u0644\u064a\u0642 \u0627\u0644\u0628\u0628\u062a\u064a\u062f\u0627\u062a \u062d\u0633\u0628 \u0627\u0644\u0637\u0644\u0628","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u0627\u0644\u0641\u0631\u064a\u0642 \u0627\u0644\u0641\u0646\u064a NHD","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"\u064a\u062d\u062a\u0641\u0638 \u0641\u0631\u064a\u0642 NHD \u0627\u0644\u0641\u0646\u064a \u0628\u0648\u062b\u0627\u0626\u0642 \u0643\u062a\u0627\u0644\u0648\u062c \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0628\u062d\u062b\u064a \u0648\u0645\u0644\u062e\u0635\u0627\u062a \u0627\u0644\u0623\u062f\u0644\u0629. \u062a\u0631\u062a\u0628\u0637 \u0627\u0644\u0645\u0642\u0627\u0644\u0627\u062a \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627 \u0628\u0627\u0644\u0623\u0648\u0631\u0627\u0642 \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627 \u0645\u0646 \u0642\u0628\u0644 \u0627\u0644\u0646\u0638\u0631\u0627\u0621\u060c \u0648\u0633\u062c\u0644\u0627\u062a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0648\u0627\u0644\u0633\u062c\u0644\u0627\u062a \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629\u060c \u0648\u062a\u062d\u062a\u0641\u0638 \u0628\u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0641\u0627\u0631\u063a\u0629 \u0648\u0642\u064a\u0648\u062f \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0648\u062a\u0645\u064a\u0632 \u0627\u0644\u062a\u062f\u062e\u0644\u0627\u062a \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0639\u0646 \u0645\u0648\u0627\u062f \u0627\u0644\u0643\u062a\u0627\u0644\u0648\u062c. \u064a\u0645\u0643\u0646 \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0635\u064a\u0627\u063a\u0629 \u0628\u0645\u0633\u0627\u0639\u062f\u0629 AI \u0644\u0644\u0647\u064a\u0643\u0644\u061b \u062a\u0638\u0644 \u0631\u0648\u0627\u0628\u0637 \u0627\u0644\u0645\u0635\u062f\u0631 \u0648\u062d\u062f\u0648\u062f \u0627\u0644\u0623\u062f\u0644\u0629 \u0645\u0631\u0626\u064a\u0629. \u0647\u0630\u0627 \u0627\u0644\u0639\u0645\u0644 \u0644\u064a\u0633 \u0645\u0631\u0627\u062c\u0639\u0629 \u0623\u0642\u0631\u0627\u0646 \u0645\u0633\u062a\u0642\u0644\u0629 \u0623\u0648 \u0646\u0635\u064a\u062d\u0629 \u0637\u0628\u064a\u0629.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/ar\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/comments?post=450"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/450\/revisions"}],"predecessor-version":[{"id":530,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/450\/revisions\/530"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/media\/620"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/media?parent=450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/categories?post=450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/tags?post=450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}